Figure 6. Sequencing results of the tumor associated calcium signal transducer 2 (TACSTD2) gene in the family. Partial nucleotide sequence of the patient (P) shows the novel mutation c.356G>A (C119Y) in comparison to normal control sequence (C). The reverse complement of the partial nucleotide sequence of the mother (RM) shows the change in heterozygous state. Arrowheads indicate position of the mutation.